These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 28032208)

  • 1. Hormone replacement therapy in Turner syndrome is important-a new meta-analysis points at many shortcomings in the available literature.
    Gravholt CH
    Endocrine; 2017 Feb; 55(2):329-330. PubMed ID: 28032208
    [No Abstract]   [Full Text] [Related]  

  • 2. Homozygosity of the d3-growth hormone receptor polymorphism is associated with a high total effect of GH on growth and a low BMI in girls with Turner syndrome.
    Binder G; Trebar B; Baur F; Schweizer R; Ranke MB
    Clin Endocrinol (Oxf); 2008 Apr; 68(4):567-72. PubMed ID: 17973940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination growth hormone and estrogen increase bone mineralization in girls with Turner syndrome.
    Beckett PR; Copeland KC; Flannery TK; Sherman LD; Abrams SA
    Pediatr Res; 1999 May; 45(5 Pt 1):709-13. PubMed ID: 10231869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypogonadism and Sex Steroid Replacement Therapy in Girls with Turner Syndrome.
    Gawlik A; Hankus M; Such K; Drosdzol-Cop A; Madej P; Borkowska M; Zachurzok A; Malecka-Tendera E
    J Pediatr Adolesc Gynecol; 2016 Dec; 29(6):542-550. PubMed ID: 27018757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of cardiovascular disease in Turner syndrome.
    Thomas J; Yetman AT
    Expert Rev Cardiovasc Ther; 2009 Dec; 7(12):1631-41. PubMed ID: 19954324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Turner's syndrome.
    Sybert VP; McCauley E
    N Engl J Med; 2004 Sep; 351(12):1227-38. PubMed ID: 15371580
    [No Abstract]   [Full Text] [Related]  

  • 7. Coexisting diseases modifying each other’s presentation - lack of growth failure in Turner syndrome due to the associated pituitary gigantism.
    Dragović T; Đuran Z; Jelić S; Marinković D; Kiković S; Kuzmić-Janković S; Hajduković Z
    Vojnosanit Pregl; 2016 Oct; 73(10):961-6. PubMed ID: 29328563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Body composition and physical fitness are major determinants of the growth hormone-insulin-like growth factor axis aberrations in adult Turner's syndrome, with important modulations by treatment with 17 beta-estradiol.
    Gravholt CH; Naeraa RW; Fisker S; Christiansen JS
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2570-7. PubMed ID: 9253336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone replacement treatment in Turner syndrome.
    Kanaka-Gantenbein C
    Pediatr Endocrinol Rev; 2006 Jan; 3 Suppl 1():214-8. PubMed ID: 16641863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monozygotic twins with Turner syndrome develop slipped capital femoral epiphysis on growth hormone therapy.
    Nabhan ZM; Eugster EA
    Pediatrics; 2006 Dec; 118(6):e1900-3. PubMed ID: 17088401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Turner syndrome: diagnosis and management.
    Morgan T
    Am Fam Physician; 2007 Aug; 76(3):405-10. PubMed ID: 17708142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The future of research into growth hormone responsiveness.
    Rosenfeld RG
    Horm Res; 2009 Apr; 71 Suppl 2():71-4. PubMed ID: 19407500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The exon 3-deleted/full-length growth hormone receptor polymorphism and response to growth hormone therapy in growth hormone deficiency and Turner syndrome: a multicenter study.
    Baş F; Darendeliler F; Aycan Z; Çetinkaya E; Berberoğlu M; Sıklar Z; Öcal G; Timirci Ö; Çetinkaya S; Darcan Ş; Gökşen Şimşek D; Bideci A; Cinaz P; Böber E; Demir K; Bereket A; Turan S; Atabek ME; Tütüncüler F; Isbir T; Bozkurt N; Kabataş Eryılmaz S; Uzunhan O; Küçükemre Aydın B; Bundak R
    Horm Res Paediatr; 2012; 77(2):85-93. PubMed ID: 22456308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of growth arrest in gonadal dysgenesis: response to exogenous human growth hormone.
    FORBES AP; JACOBSEN JG; CARROLL EL; PECHET MM
    Metabolism; 1962 Jan; 11():56-75. PubMed ID: 13893992
    [No Abstract]   [Full Text] [Related]  

  • 15. Growth hormone positive effects on craniofacial complex in Turner syndrome.
    Juloski J; Dumančić J; Šćepan I; Lauc T; Milašin J; Kaić Z; Dumić M; Babić M
    Arch Oral Biol; 2016 Nov; 71():10-15. PubMed ID: 27372203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acceleration of growth in Turner syndrome patients treated with growth hormone: summary of three-year results.
    Rosenfeld RG
    J Endocrinol Invest; 1989; 12(8 Suppl 3):49-51. PubMed ID: 2681348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Turner syndrome and clinical treatment.
    Hjerrild BE; Mortensen KH; Gravholt CH
    Br Med Bull; 2008; 86():77-93. PubMed ID: 18400842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results of growth hormone treatment in girls with Turner syndrome].
    Rongen-Westerlaken C
    Tijdschr Kindergeneeskd; 1988 May; 56 Suppl 1():31-2. PubMed ID: 3413772
    [No Abstract]   [Full Text] [Related]  

  • 19. Hormone replacement therapy in children: The use of growth hormone and IGF-I.
    Pfäffle R
    Best Pract Res Clin Endocrinol Metab; 2015 Jun; 29(3):339-52. PubMed ID: 26051295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of growth hormone therapy on adult height of children with Turner syndrome.
    Hsu PY; Tung YC; Tsai WY; Lee JS; Hsiao PH
    J Formos Med Assoc; 2008 Sep; 107(9):704-9. PubMed ID: 18796360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.